From: Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
 | A2780 | A2780cisR | RF | A2780ZD0473R | RF | SKOV-3 | RF |
---|---|---|---|---|---|---|---|
CS | 0.5 ± 0.03 | 8.2 ± 0.6 | 17.7 | 6.0 ± 0.5 | 13.0 | 10.2 ± 0.5 | 22.2 |
CB | 14.0 ± 1.4 | 48.9 ± 3.9 | 3.5 | 64.6 ± 3.2 | 4.6 | 43.4 ± 3.9 | 3.1 |
OX | 0.2 ± 0.01 | 0.4 ± 0.02 | 1.9 | 0.4 ± 0.03 | 2.1 | 43.6 ± 3.0 | 229.4 |
CH1 | 21.3 ± 2.0 | 26.6 ± 1.9 | 1.2 | 25.4 ± 1.7 | 1.2 | 29.8 ± 1.8 | 1.4 |
BORT | 0.05 ± 0.01 | 0.05 ± 0.01 | 1.0 | 0.04 ± 0.01 | 0.8 | 0.09 ± 0.01 | 1.8 |